| Autor: |
Jane A Buxton, Danuta M Skowronski, Helen Ng, Steve A Marion, Michele Williams, Anna Forbes, Arlene King, Jamie Hockin |
| Jazyk: |
angličtina |
| Rok vydání: |
2001 |
| Předmět: |
|
| Zdroj: |
Canadian Journal of Infectious Diseases, Vol 12, Iss 5, Pp 285-288 (2001) |
| Druh dokumentu: |
article |
| ISSN: |
1180-2332 |
| DOI: |
10.1155/2001/926732 |
| Popis: |
BACKGROUND: Amantadine, an antiviral agent, is the only drug currently approved in Canada for prophylaxis of influenza A virus infection. To minimize side effects, the amantadine dose is adjusted for age and estimated creatinine clearance (CrCl) based on plasma creatinine (Cr) levels. As amantadine is used more frequently for influenza A outbreak control in care facilities for elderly people, physicians are increasingly called on to prescribe it for residents and to consider the necessity of requesting plasma Cr levels. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
